SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029111
Filing Date
2014-05-09
Accepted
2014-05-09 16:48:33
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v376448_10q.htm 10-Q 349243
2 EXHIBIT 31.1 v376448_ex31-1.htm EX-31.1 9068
3 EXHIBIT 31.2 v376448_ex31-2.htm EX-31.2 10672
4 EXHIBIT 32.1 v376448_ex32-1.htm EX-32.1 4262
5 EXHIBIT 32.2 v376448_ex32-2.htm EX-32.2 4401
  Complete submission text file 0001144204-14-029111.txt   3293746

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20140331.xml EX-101.INS 401137
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20140331.xsd EX-101.SCH 39708
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20140331_cal.xml EX-101.CAL 25612
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20140331_def.xml EX-101.DEF 180731
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20140331_lab.xml EX-101.LAB 249557
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20140331_pre.xml EX-101.PRE 212627
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 14829834
SIC: 2836 Biological Products, (No Diagnostic Substances)